Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.

Baek HJ, Park HJ, Sung KW, Lee SH, Han JW, Koh KN, Im HJ, Kang HJ, Park KD.

J Neurooncol. 2013 Sep;114(3):329-38. doi: 10.1007/s11060-013-1188-1. Epub 2013 Jul 4.

PMID:
23824533
2.

Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.

Park ES, Sung KW, Baek HJ, Park KD, Park HJ, Won SC, Lim DH, Kim HS.

J Korean Med Sci. 2012 Feb;27(2):135-40. doi: 10.3346/jkms.2012.27.2.135. Epub 2012 Jan 27.

3.

Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.

Sung KW, Lim DH, Son MH, Lee SH, Yoo KH, Koo HH, Kim JH, Suh YL, Joung YS, Shin HJ.

Neuro Oncol. 2013 Mar;15(3):352-9. doi: 10.1093/neuonc/nos304. Epub 2012 Dec 20.

5.
6.

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.

Nieto Y, Tu SM, Bassett R, Jones RB, Gulbis AM, Tannir N, Kingham A, Ledesma C, Margolin K, Holmberg L, Champlin R, Pagliaro L.

Ann Oncol. 2015 Oct;26(10):2125-32. doi: 10.1093/annonc/mdv310. Epub 2015 Jul 21. Erratum in: Ann Oncol. 2015 Dec;26(12):2507-8.

7.

High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.

Lewin J, Dickinson M, Voskoboynik M, Collins M, Ritchie D, Toner G.

Intern Med J. 2014 Aug;44(8):771-8. doi: 10.1111/imj.12486.

PMID:
24893627
8.

A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.

Selle F, Wittnebel S, Biron P, Gravis G, Roubaud G, Bui BN, Delva R, Bay JO, Fléchon A, Geoffrois L, Caty A, Soares DG, de Revel T, Fizazi K, Gligorov J, Micléa JM, Dubot C, Provent S, Temby I, Gaulet M, Horn E, Brindel I, Lotz JP.

Ann Oncol. 2014 Sep;25(9):1775-82. doi: 10.1093/annonc/mdu198. Epub 2014 Jun 3.

PMID:
24894084
9.

High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.

Pico JL, Fadel E, Ibrahim A, Bourhis JH, Droz JP.

Bull Cancer. 1995;82 Suppl 1:56s-60s. Review.

PMID:
7542945
10.

Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.

Modak S, Gardner S, Dunkel IJ, Balmaceda C, Rosenblum MK, Miller DC, Halpern S, Finlay JL.

J Clin Oncol. 2004 May 15;22(10):1934-43.

PMID:
15143087
11.

Salvage therapy with high-dose chemotherapy and peripheral blood stem cell transplant in patients with primary mediastinal nonseminomatous germ cell tumors.

Suleiman Y, Siddiqui BK, Brames MJ, Abonour R, Einhorn LH.

Biol Blood Marrow Transplant. 2013 Jan;19(1):161-3. doi: 10.1016/j.bbmt.2012.08.002. Epub 2012 Aug 11.

12.

Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.

Czyzewski EA, Goldman S, Mundt AJ, Nachman J, Rubin C, Hallahan DE.

Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):569-77.

PMID:
10348286
13.

Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.

Avramova B, Jordanova M, Michailov G, Konstantinov D, Christosova I, Bobev D.

J BUON. 2006 Oct-Dec;11(4):433-8.

PMID:
17309174
14.

Efficacy of high-dose chemotherapy and autologous stem cell transplantation in patients with relapsed medulloblastoma: a report on the Korean Society for Pediatric Neuro-Oncology (KSPNO)-S-053 study.

Park JE, Kang J, Yoo KH, Sung KW, Koo HH, Lim DH, Shin HJ, Kang HJ, Park KD, Shin HY, Kim IH, Cho BK, Im HJ, Seo JJ, Park HJ, Park BK, Ahn HS.

J Korean Med Sci. 2010 Aug;25(8):1160-6. doi: 10.3346/jkms.2010.25.8.1160. Epub 2010 Jul 21.

15.

Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?

Banna GL, De Giorgi U, Ferrari B, Castagna L, Alloisio M, Marangolo M, Rosti G, Santoro A.

Biol Blood Marrow Transplant. 2006 Oct;12(10):1085-91.

16.

Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma.

Zia MI, Forsyth P, Chaudhry A, Russell J, Stewart DA.

Bone Marrow Transplant. 2002 Nov;30(9):565-9.

17.

Toxicity of tandem high-dose chemotherapy and autologous stem cell transplantation using carboplatin-thiotepa-etoposide and cyclophosphamide-melphalan regimens for malignant brain tumors in children and young adults.

Lee SH, Son MH, Sung KW, Choi YB, Lee NH, Yoo KH, Koo HH, Lim DH, Shin HJ.

J Neurooncol. 2014 Dec;120(3):507-13. doi: 10.1007/s11060-014-1576-1. Epub 2014 Aug 10.

PMID:
25108776
18.

Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.

Margolin KA, Doroshow JH, Frankel P, Chow W, Leong LA, Lim D, McNamara M, Morgan RJ, Shibata S, Somlo G, Twardowski P, Yen Y, Kogut N, Schriber J, Alvarnas J, Stalter S.

Biol Blood Marrow Transplant. 2005 Nov;11(11):903-11.

19.

A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors.

Rosenfeld A, Kletzel M, Duerst R, Jacobsohn D, Haut P, Weinstein J, Rademaker A, Schaefer C, Evans L, Fouts M, Goldman S.

J Neurooncol. 2010 Apr;97(2):247-55. doi: 10.1007/s11060-009-0009-z. Epub 2009 Sep 21.

PMID:
19768658
20.

The clinical characteristics and treatment outcome of 57 children and adolescents with primary central nervous system germ cell tumors.

Sun XF, Zhang F, Zhen ZJ, Yang QY, Xia YF, Wu SX, Zhu J, Lu SY, Wang J, Sun FF, Cai RQ, Chen Y, Li PF.

Chin J Cancer. 2014 Aug;33(8):395-401. doi: 10.5732/cjc.013.10112. Epub 2014 Jul 3.

Supplemental Content

Support Center